Stony Brook Psychiatric Associates

Ketamine intra-nasal therapy is one of the cornerstones of the Treatment-Resistant Depression (TRD) Program at Stony Brook Psychiatric Associates. Individuals whose experience with conventional therapies has been disappointing can explore an alternative and cutting-edge therapy with the Stony Brook team. Ketamine has been in use as an anesthetic since the early 1970s, but recent research has also identified it as a safe and effective psychiatric medication. Studies show that 1 in 3 people suffering from do not respond to multiple oral medications. The ketamine treatments at Stony Brook Psychiatric provide an alternative to chronic pain and suffering. *Interested in joining a Psychedelics Clinical Trial? and we will connect you with a clinical trial in your area when one becomes available.* Dr. Lucian Manu leads the TRD team at Stony Brook Psychiatric Associates. Alongside a team of psychiatrists, nurses, and technicians, Dr. Manu provides intra-nasal ketamine therapy to those suffering from difficult to manage conditions. Dr. Manu sees psychiatry as being "at a stage where there are new and exciting technologies and treatment solutions," foremost amongst them. They also offer, which can be covered by insurance for certain conditions. Treatments are administered at the comfortable and private Stony Brook Psychiatric Associates offices, and help is available to anyone whose life has been severely impacted by the symptoms of a treatment-resistant mental health condition. Offered Treatments Intra-Nasal Ketamine Therapy (Esketamine) TMS Therapy (Transcranial Magnetic Stimulation) Treated Conditions Treatment-Resistant Depression Important Info Please contact the clinic for information regarding fees, insurance, and possible contraindications to ketamine therapy. https://www.youtube.com/watch?v=154Or_KlTRE Your Treatment: What to Expect Patients in the Stony Brook Psychiatric Associates Treatment-Resistant Depression program are first subjected to a thorough mental and physical health screening. After the screening, a treatment plan is created. This will likely involve an induction phase (the amount of time required for your body to acclimate to ketamine in it) and a maintenance phase. During the first phase, ketamine treatments take place twice a week for four weeks. Based on the patient's response to treatment, subsequent maintenance treatments then take place once a week or once every two weeks. Each treatment is monitored in Stony Brook's office for 120 minutes. Some patients experience mild side effects, such as nausea or dissociation, but these fade after the treatment period has ended. Also Read: Who is this treatment for? Ketamine treatments in the Treatment-Resistant Depression program at Stony Brook Psychiatric Associates are for individuals who have tried two or more conventional medications and therapies and have found little to no improvement in the negative symptoms of their condition. Put another way, "the tools an individual has to help, don't match the extent of the challenges and magnitude of the problems the person faces." The team at Stony Brook Psychiatric hopes to provide new tools to those facing these overwhelming challenges. Discover Other New York Ketamine Clinic Listings